Globus Medical, Inc. (NYSE:GMED) Q3 2022 Earnings Conference Call November 8, 2022 4:30 PM ET
Company Participants
Brian Kearns - Senior Vice President, Business Development and Investor Relations
Dan Scavilla - President and CEO
Keith Pfeil - Senior Vice President and Chief Financial Officer
Conference Call Participants
Matt Miksic - Barclays
Vik Chopra - Wells Fargo
Shagun Singh - RBC
Richard Newitter - Truist
Matt O’Brien - Piper Sandler
David Saxon - Needham and Company
Caitlin Cronin - Canaccord Genuity
Operator
Welcome to Globus Medical’s Third Quarter 2022 Earnings Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today’s conference is being recorded.
I will now turn the call over to Brian Kearns, Senior Vice President of Business Development and Investor Relations. Mr. Kearns, please go ahead.
Brian Kearns
Thank you, Stacey and thank you, everyone for being with us today. Joining today’s call from Globus Medical will be Dan Scavilla, President and CEO; and Keith Pfeil, Senior Vice President and Chief Financial Officer. This review is being made available via webcast, accessible through the Investor Relations section of the Globus Medical website at www.globusmedical.com.
Before we begin, let me remind you that some of the statements made during this review are or may be considered forward-looking statements. Our Form 10-K for the 2021 fiscal year, and our subsequent filings with the Securities and Exchange Commission identifies certain factors that could cause our actual results to differ materially from those projected in any forward-looking statements made today. Our SEC filings, including the 10-K are available on our website.
We do not undertake to update any forward-looking statements as a result of new information or future events or developments. Our discussion today will also include certain financial measures that are not calculated in accordance with Generally Accepted Accounting Principles or GAAP. We believe these non-GAAP financial measures provide additional information pertinent to our business performance.
These non-GAAP financial measures should not be considered replacements for and should be read together with the most directly comparable GAAP financial measures. Reconciliations to the mostly – most directly comparable GAAP measures are available on the schedules accompanying the press release and on the Investor Relations section of the Globus Medical website.
With that, I will now turn the call over to Dan Scavilla, our President and CEO.